These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 4502562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Principle defects which account for shock following acute myocardial infarction in man: implications for treatment.
    Mueller H, Ayres SM, Grace WJ.
    Crit Care Med; 1973; 1(1):27-38. PubMed ID: 4757962
    [No Abstract] [Full Text] [Related]

  • 3. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
    Mueller H, Ayres SM, Giannelli S, Conklin EF, Mazzara JT, Grace WJ.
    Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical experience with a new cardiac assist device. The dual-chambered intra-aortic balloon assist.
    Bregman D, Goetz RH.
    J Thorac Cardiovasc Surg; 1971 Oct; 62(4):577-91. PubMed ID: 5093815
    [No Abstract] [Full Text] [Related]

  • 7. Effects of intra-aortic balloon pumping on coronary flow and metabolism in man.
    Leinbach RC, Buckley MJ, Austen WG, Petschek HE, Kantrowitz AR, Sanders CA.
    Circulation; 1971 May; 43(5 Suppl):I77-81. PubMed ID: 5317852
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Shock in myocardial infarction--medical treatment.
    Kuhn LA.
    Am J Cardiol; 1970 Dec; 26(6):578-87. PubMed ID: 4938984
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inotropic agents in the treatment of cardiogenic shock.
    Bourdarias JP, Dubourg O, Gueret P, Ferrier A, Bardet J.
    Pharmacol Ther; 1983 Dec; 22(1):53-79. PubMed ID: 6361798
    [No Abstract] [Full Text] [Related]

  • 13. Cardiogenic shock. Recent advances in pharmacologic management. II.
    Kones RJ.
    N Y State J Med; 1973 Aug 01; 73(15):1967-80. PubMed ID: 4354585
    [No Abstract] [Full Text] [Related]

  • 14. Mechanical circulatory assistance. Present status.
    Kones RJ.
    N Y State J Med; 1974 Mar 01; 74(3):516-31. PubMed ID: 4594914
    [No Abstract] [Full Text] [Related]

  • 15. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS.
    Am J Cardiol; 1974 Apr 01; 33(4):521-8. PubMed ID: 4818050
    [No Abstract] [Full Text] [Related]

  • 16. Haemodynamics and coronary blood flow in cases of counterpulsation.
    Chazov EI, Ruda YA, Trubetskoy AV.
    G Ital Cardiol; 1971 Apr 01; 1(6):506-19. PubMed ID: 5136530
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of noninvasive systolic unloading (nitroprusside) and diastolic augmentation (external counterpulsation) in patients with acute myocardial infarction.
    Parmley WW, Chatterjee K, Charuzi Y, Swan HJ.
    Am J Cardiol; 1974 Jun 01; 33(7):819-25. PubMed ID: 4829364
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physiologic basis for the therapeutic use of catecholamines.
    Rosenblum R.
    Am Heart J; 1974 Apr 01; 87(4):527-30. PubMed ID: 4817111
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.